BME frontiers最新文献

{"title":"A Novel System for Fabricating Microspheres with Microelectromechanical System-Based Bioprinting Technology.","authors":"Yifeng Xu, Bao Jiang, Fangfang Liu, Hua Zhang, Dan Li, Xiaohui Tang, Xiuming Yang, Yan Sheng, Xuanye Wu, Nan Shi","doi":"10.34133/bmef.0076","DOIUrl":"https://doi.org/10.34133/bmef.0076","url":null,"abstract":"<p><p><b>Objective and Impact Statement:</b> The microspheres were widely utilized in the field of life sciences, and we have developed an innovative microelectromechanical system (MEMS)-based bioprinting technology (MBT) system for the preparation of the microspheres. The microspheres can be automatically and high-throughput produced with this cutting-edge system. <b>Introduction and Methods:</b> This paper mainly introduced a novel, efficient, and cost-effective approach for the microsphere fabrication with the MBT system. In this work, the whole microsphere production equipment was built and the optimal conditions (like concentration, drying temperature, frequency, and voltage) for generating uniform hydroxypropyl cellulose-cyclosporine A (HPC-CsA) and poly-l-lactic acid (PLLA) microspheres were explored. <b>Results:</b> Results demonstrated that the optimal uniformity of HPC-CsA microspheres was achieved at 2% (w/v) HPC-CsA mixture, 45 °C (drying temperature), 1,000 Hz (frequency), and 25 V (voltage amplitude). CsA microspheres [coefficient of variation (CV): ~9%] are successfully synthesized, and the drug encapsulation rate was 84.8%. The methodology was further used to produce PLLA microspheres with a diameter of ~2.55 μm, and the best CV value achieved 6.84%. <b>Conclusion:</b> This investigation fully highlighted the integration of MEMS and bioprinting as a promising tool for the microsphere fabrication, and this MBT system had huge potential applications in pharmaceutical formulations and medical aesthetics.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0076"},"PeriodicalIF":5.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cationized Decalcified Bone Matrix for Infected Bone Defect Treatment.","authors":"Le Chen, Yuying Ai, Ruonan Wu, Zhaoyan Guo, Yang Li, Jie Li, Feng Qu, Shun Duan, Fu-Jian Xu","doi":"10.34133/bmef.0066","DOIUrl":"10.34133/bmef.0066","url":null,"abstract":"<p><p><b>Objective:</b> We aim to develop a dual-functional bone regeneration scaffold (Q<i>x</i>-D) with antibacterial and osteogenic properties for infected bone defect treatment. <b>Impact Statement:</b> This study provides insights into antibacterial components that could be combined with naturally derived materials through a facile Schiff base reaction, offering a potential strategy to enhance antibacterial properties. <b>Introduction:</b> Naturally derived decalcified bone matrix (DBM) has been reported to be porous and biodegradable. DBM can induce various cell differentiations and participate in immune regulation, making it an ideal bone regeneration scaffold for bone defects. However, DBM does not exhibit antimicrobial properties. Therefore, it is essential to develop antibacterial functionalization method for DBM. <b>Methods:</b> DBM was modified with a macromolecular quaternary ammonium salt (QPEI). A series of Q<i>x</i>-D with tunable feeding ratios were synthesized through Schiff base reaction. The morphology, chemical property, in vitro antibacterial efficiency, in vitro biocompatibility, osteogenic property, and in vivo anti-infection performances were characterized. <b>Results:</b> All Q<i>x</i>-D exhibited marked antibacterial properties. Small adjustments in feed concentration could not induce changes in antibacterial properties. However, cell viability slightly decreased with increasing feed concentration. Q10-D demonstrated significant antibacterial properties and could promote recovery of infected bone defect in an animal model. <b>Conclusion:</b> Q<i>x</i>-D shows marked antibacterial properties and good biocompatibility. Moreover, Q10-D could be a potential choice for infected bone defects.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0066"},"PeriodicalIF":5.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Janus Adhesive Hydrogel with Integrated Attack and Defense for Bacteria Killing and Antifouling.","authors":"Kai Ren, Xiang Ke, Miao Zhang, Yuan Ding, Hao Wang, Hong Chen, Jing Xie, Jianshu Li","doi":"10.34133/bmef.0059","DOIUrl":"10.34133/bmef.0059","url":null,"abstract":"<p><p><b>Objective:</b> Skin wound exposed to complex external environment for a long time is highly susceptible to bacterial infection. <b>Impact Statement:</b> This work designs a Janus adhesive dual-layer hydrogel containing in situ silver nanoparticles (named PSAP/DXP@AgNPs) with integrated attack and defense to simultaneously kill the existing bacteria and prevent foreign bacterial contamination. <b>Introduction:</b> The current gauze dressing fixed by tape fails to well fit at skin wound and lacks intrinsic antibacterial property, making it highly prone to causing secondary infection. Moreover, foreign bacteria may contaminate the wound dressing during use, further increasing the risk of secondary infection. <b>Methods:</b> In this work, a Janus adhesive dual-layer PSAP/DXP@AgNPs hydrogel is prepared by sequentially building the PSAP gel layer containing zwitterionic poly(sulfobetaine methacrylamide) (PSBMA) on the DXP@AgNPs gel layer containing in situ catechol-reduced AgNPs. <b>Results:</b> The flexible PSAP/DXP@AgNPs can adapt shape change of skin and adhere to skin tissue with interfacial toughness of 153.38 J m^-2 relying on its DXP@AgNPs layer, which is beneficial to build favorable fit. The in situ reduced AgNPs released from the DXP@AgNPs layer of PSAP/DXP@AgNPs exhibit obvious antibacterial effects against <i>Escherichia coli</i> and <i>Staphylococcus aureus</i>, with antibacterial rates of 99% and 88%, respectively. Meanwhile, the hydrated PSAP layer of PSAP/DXP@AgNPs containing PSBMA is able to prevent the bacterial contamination, decreasing the risk of secondary infection. Besides, cell experiments demonstrate that PSAP/DXP@AgNPs is biocompatible. <b>Conclusion:</b> The PSAP/DXP@AgNPs hydrogel with integrated attack and defense simultaneously possessing bacteria-killing and bacteria-antifouling properties is a potential alternative in treating infected skin wound.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0059"},"PeriodicalIF":5.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Functional Neural Networks in Human Brain Organoids.","authors":"Longjun Gu, Hongwei Cai, Lei Chen, Mingxia Gu, Jason Tchieu, Feng Guo","doi":"10.34133/bmef.0065","DOIUrl":"10.34133/bmef.0065","url":null,"abstract":"<p><p>Human brain organoids are 3-dimensional brain-like tissues derived from human pluripotent stem cells and hold promising potential for modeling neurological, psychiatric, and developmental disorders. While the molecular and cellular aspects of human brain organoids have been intensively studied, their functional properties such as organoid neural networks (ONNs) are largely understudied. Here, we summarize recent research advances in understanding, characterization, and application of functional ONNs in human brain organoids. We first discuss the formation of ONNs and follow up with characterization strategies including microelectrode array (MEA) technology and calcium imaging. Moreover, we highlight recent studies utilizing ONNs to investigate neurological diseases such as Rett syndrome and Alzheimer's disease. Finally, we provide our perspectives on the future challenges and opportunities for using ONNs in basic research and translational applications.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0065"},"PeriodicalIF":5.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What Is the Magical Cavitation Bubble: A Holistic Perspective to Trigger Advanced Bubbles, Nano-Sonocatalysts, and Cellular Sonosensitizers.","authors":"Xiaoge Wu, Fulong Chen, Qi Zhang, Juan Tu","doi":"10.34133/bmef.0067","DOIUrl":"https://doi.org/10.34133/bmef.0067","url":null,"abstract":"<p><p>Sonodynamic therapy (SDT) has emerged as a novel and highly researched advancement in the medical field. Traditional ultrasound contrast agents and novel bubble-shaped agents are used to stimulate cavitation and enhance SDT efficiency. However, the impact of artificially modified shell structures on the acoustic properties of microbubbles remains to be explored. Alternatively, in the absence of bubble-shaped agents, some clinically available organic sonosensitizers and advanced inorganic materials are also used to enhance the efficacy of SDT. Diagnostic and therapeutic ultrasound can also activate cavitation bubbles, which supply energy to sonosensitive agents, leading to the production of cytotoxic free radicals to achieve therapeutic effects. While inorganic materials often spark controversy in clinical applications, their relatively simple structure enables researchers to gain insight into the mechanism by which SDT produces various free radicals. Some organic-inorganic hybrid sonosensitive systems have also been reported, combining the benefits of inorganic and organic sonosensitive agents. Alternatively, by employing cell surface modification engineering to enable cells to perform functions such as immune escape, drug loading, gas loading, and sonosensitivity, cellular sonosensitizers have also been developed. However, further exploration is needed on the acoustic properties, ability to generate reactive oxygen species (ROS), and potential clinical application of this cellular sonosensitizer. This review offers a comprehensive analysis of vesical microbubbles and nanoscale sonocatalysts, including organic, inorganic, combined organic-inorganic sonosensitizers, and cellular sonosensitizers. This analysis will enhance our understanding of SDT and demonstrate its important potential in transforming medical applications.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0067"},"PeriodicalIF":5.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Synergistic Assembly of 1DZnO and Anti-CYFRA 21-1: A Physicochemical Approach to Optical Biosensing.","authors":"Rafael A Salinas, Shirlley E Martínez Tolibia, Patricia G Zayas-Bazán, Sandra E Rodil, Mathew T Mathew, Andrés Navarrete, Guillermo Santana, Ateet Dutt","doi":"10.34133/bmef.0064","DOIUrl":"https://doi.org/10.34133/bmef.0064","url":null,"abstract":"<p><p><b>Objective:</b> We conducted a comprehensive physicochemical analysis of one-dimensional ZnO nanowires (1DZnO), incorporating anti-CYFRA 21-1 immobilization to promote fast optical biomarker detection up to 10 ng ml^-1. <b>Impact Statement:</b> This study highlights the effectiveness of proof-of-concept 1DZnO nanoplatforms for rapid cancer biomarker detection by examining the nanoscale integration of 1DZnO with these bioreceptors to deliver reliable photoluminescent output signals. <b>Introduction:</b> The urgent need for swift and accurate prognoses in healthcare settings drives the rise of sensitive biosensing nanoplatforms for cancer detection, which has benefited from biomarker identification. CYFRA 21-1 is a reliable target for the early prediction of cancer formation that can be perceptible in blood, saliva, and serum. However, 1DZnO nanostructures have been barely applied for CYFRA 21-1 detection. <b>Methods:</b> We assessed the nanoscale interaction between 1DZnO and anti-CYFRA 21-1 antibodies to develop rapid CYFRA 21-1 detection in two distinct matrices: PhosphateBuffered Saline (PBS) buffer and artificial saliva. The chemical modifications were tracked utilizing Fourier transform infrared spectroscopy, while transmission electron microscopy and energy dispersive spectroscopy confirmed antigen-antibody interplay over nanostructures. <b>Results:</b> Our results show high antibody immobilization efficiencies, affirming the effectiveness of 1DZnO nanoplatforms for rapid CYFRA 21-1 testing within a 5-min detection window in both PBS and artificial saliva. Photoluminescence measurements also revealed distinct optical responses across biomarker concentrations ranging from 10 to 1,000 ng ml^-1. <b>Conclusion:</b> Discernible PL signal responses obtained after 5 min affirm the potential of 1DZnO nanoplatforms for further advancement in optical biomarker detection for application in early cancer prognosis.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0064"},"PeriodicalIF":5.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11408934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tissue Optical Clearing Imaging from Ex vivo toward In vivo.","authors":"Dan Zhu, Valery Tuchin","doi":"10.34133/bmef.0058","DOIUrl":"https://doi.org/10.34133/bmef.0058","url":null,"abstract":"","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0058"},"PeriodicalIF":5.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11391214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Automated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling.","authors":"Sahan Yoruc Selcuk, Xilin Yang, Bijie Bai, Yijie Zhang, Yuzhu Li, Musa Aydin, Aras Firat Unal, Aditya Gomatam, Zhen Guo, Darrow Morgan Angus, Goren Kolodney, Karine Atlan, Tal Keidar Haran, Nir Pillar, Aydogan Ozcan","doi":"10.34133/bmef.0048","DOIUrl":"10.34133/bmef.0048","url":null,"abstract":"<p><p><b>Objective and Impact Statement:</b> Human epidermal growth factor receptor 2 (HER2) is a critical protein in cancer cell growth that signifies the aggressiveness of breast cancer (BC) and helps predict its prognosis. Here, we introduce a deep learning-based approach utilizing pyramid sampling for the automated classification of HER2 status in immunohistochemically (IHC) stained BC tissue images. <b>Introduction:</b> Accurate assessment of IHC-stained tissue slides for HER2 expression levels is essential for both treatment guidance and understanding of cancer mechanisms. Nevertheless, the traditional workflow of manual examination by board-certified pathologists encounters challenges, including inter- and intra-observer inconsistency and extended turnaround times. <b>Methods:</b> Our deep learning-based method analyzes morphological features at various spatial scales, efficiently managing the computational load and facilitating a detailed examination of cellular and larger-scale tissue-level details. <b>Results:</b> This approach addresses the tissue heterogeneity of HER2 expression by providing a comprehensive view, leading to a blind testing classification accuracy of 84.70%, on a dataset of 523 core images from tissue microarrays. <b>Conclusion:</b> This automated system, proving reliable as an adjunct pathology tool, has the potential to enhance diagnostic precision and evaluation speed, and might substantially impact cancer treatment planning.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0048"},"PeriodicalIF":5.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141753512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Controllable Thrombolysis Using a Nanobubble-Imaging-Guided rtPA Targeted Delivery Strategy.","authors":"Jian Tang, Huiting Xu, Mingxi Li, Yang Liu, Fang Yang","doi":"10.34133/bmef.0040","DOIUrl":"10.34133/bmef.0040","url":null,"abstract":"<p><p><b>Objective:</b> The objective of this work is to design and fabricate a novel multifunctional nanocarrier combining thrombus-targeted imaging and ultrasound-mediated drug delivery for the theranostics of thrombotic diseases. <b>Impact Statement:</b> This study develops a new technology that can accurately visualize the thrombus and deliver drugs with controllable properties to diagnose and treat thrombotic diseases. <b>Introduction:</b> Thrombotic diseases are a serious threat to human life and health. The diagnosis and treatment of thrombotic diseases have always been a challenge. In recent years, nanomedicine has brought new ideas and new methods for the theranostics of thrombotic diseases. However, there are also many problems need to be solved, such as biosafety and stability of nanocarriers, early diagnosis, and timely treatment of thrombotic diseases, difficulty in clinical translation. <b>Methods:</b> The S1P@CD-PLGA-rtPA nanobubbles (NBs) were prepared by integrating sulfur hexafluoride (SF₆)-loaded poly (D, L-lactide-co-glycolide) (PLGA) NBs, cyclodextrin (CD), sphingosine-1-phosphate (S1P), and recombinant tissue plasminogen activator (rtPA). <b>Results:</b> S1P@CD-PLGA-rtPA NBs had rapid and excellent thrombosis targeting imaging performance based on the specific interaction of S1P-S1PR1 (sphingosine-1-phosphate receptor 1). Furthermore, S1P@CD-PLGA-rtPA NBs that specifically targeting to the thrombosis regions could also respond to external ultrasound to achieve accurate and efficient delivery of rtPA to enhance the thrombolysis effectiveness and efficiency. <b>Conclusion:</b> This study proposes a new idea and strategy of targeting thrombus in rats via the specific interaction of S1P-S1PR1. On this basis, the acoustic response properties of bubble carriers could be fully utilized by combining thrombus-specific targeted imaging and ultrasound-mediated drug delivery for effective thrombolysis, which is expected to be applied in targeted diagnosis and treatment of thrombotic diseases in the future.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0040"},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines.","authors":"Kefan Song, Suzie H Pun","doi":"10.34133/bmef.0038","DOIUrl":"10.34133/bmef.0038","url":null,"abstract":"<p><p>With the recent advances in neoantigen identification, peptide-based cancer vaccines offer substantial potential in the field of immunotherapy. However, rapid clearance, low immunogenicity, and insufficient antigen-presenting cell (APC) uptake limit the efficacy of peptide-based cancer vaccines. This review explores the barriers hindering vaccine efficiency, highlights recent advancements in synthetic delivery systems, and features strategies for the key delivery steps of lymph node (LN) drainage, APC delivery, cross-presentation strategies, and adjuvant incorporation. This paper also discusses the design of preclinical studies evaluating vaccine efficiency, including vaccine administration routes and murine tumor models.</p>","PeriodicalId":72430,"journal":{"name":"BME frontiers","volume":"5 ","pages":"0038"},"PeriodicalIF":5.0,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140186432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}